Quantitative thallium-201 scintigraphy after dipyridamole infusion combined with low level exercise in healthy volunteers.
To establish test specific normal limits for quantitative analysis of uptake and washout of 201Tl after dipyridamole infusion combined with low level exercise, 20 healthy volunteers were studied with low likelihood of coronary artery disease (CAD) assessed by a stepwise probability analysis based on age, sex, symptoms, resting electrocardiogram, and exercise electrocardiography. Likelihood of CAD in these volunteers was calculated as less than or equal to 1%. After dipyridamole infusion combined with low level exercise, one volunteer complained of headache; no other side effects were observed. There were no chest pain complaints. Maximal hemodynamic changes were achieved during the 6th and 7th min of the test. No ST segment depression was recorded. Visual analysis of the 201Tl scintigrams was normal in all volunteers. Mean regional washout at 4 h was 44.37% +/- 2.11%. The regional washout in the 70 degrees LAO view (46.65% +/- 1.10%) was significantly higher than in the anterior and 30 degrees LAO views (43.44% +/- 1.50% and 43.02% +/- 1.45%, respectively). Profiles of uptake and washout of 201Tl were different after dipyridamole infusion combined with low level exercise as compared to maximal exercise. Thus, in quantitative analysis of 201Tl scintigraphy after dipyridamole infusion in conjunction with low level exercise as applied in the present study, it is mandatory to use normal limits of uptake and washout of 201Tl derived from healthy volunteers who underwent the same combined protocol.
Laarman
G J
GJ
Department of Cardiology St. Antonius Hospital, Nieuwegein, The Netherlands.
Niemeyer
M G
MG
Bruschke
A V
AV
Verzijlbergen
F J
FJ
Go
T L
TL
van der Wall
E E
EE
Ascoop
C A
CA
D000328:Adult; D001794:Blood Pressure; D003327:Coronary Disease / Q000000981:diagnostic imaging; D004176:Dipyridamole / Q000009:adverse effects; D015444:Exercise; D006321:Heart / Q000000981:diagnostic imaging*; D006334:Heart Function Tests / Q000379:methods; D006339:Heart Rate; D006801:Humans; D008297:Male; D011877:Radionuclide Imaging; D012016:Reference Values; D013794:Thallium Radioisotopes / Q000493:pharmacokinetics
D013794:Thallium Radioisotopes; D004176:Dipyridamole